Ocera Therapeutics Inc (NASDAQ:OCRX)

Data as of 3:59pm ET
 -0.13 / -2.04%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002 ornithine phenylacetate. The OCR-002 is an ammonia scavenger which is used to treat hyperammonemia and associated hepatic encephalopathy in patients with liver cirrhosis, acute liver failure and acute liver injury. The company was founded by Wu Xiaoyun and John C. Kappes on January 12, 1998 and is headquarterd in Palo Alto, CA.

Contact Information

Ocera Therapeutics, Inc.
525 University Avenue
Palo Alto California 94301
P:(650) 475-0150
Investor Relations:



Other institutional35.24%
Mutual fund holders2.53%
Individual stakeholders1.84%

Top Executives

Linda S. GraisPresident, Chief Executive Officer & Director
Michael ByrnesChief Financial Officer, Treasurer & VP-Finance
Gaurav AggarwalChief Business Officer
Rajiv PatniChief Development Officer
Jeryl L. HillemanChief Accounting Officer & Head-Investor Relations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.